Show metadata Hide metadata

(19)

(11)

2 596 486

(13)

(51)

IPC

G01N33/68(2006-01-01)

C12Q1/25(2006-01-01)

A61K38/17(2006-01-01)

C07K14/47(2006-01-01)

C12Q1/68(2006-01-01)

(21) (22)

Application

2013113927/15, 2011-09-20

(24)

Start date

2011-09-20

(22)

Actual filing date

2011-09-20

(45)

Published

2016-09-10

(72)

Inventor

Stoll ThomasBringans ScottWinfield KayeCasey TammyDavis WendyPeters KirstenDavis TimothyLipscombe Richard

(73)

Holder

Proteomics International Pty LtdThe University Of Western Australia

BIOMARKERS ASSOCIATED WITH PRE-DIABETES, DIABETES AND DIABETES-RELATED CONDITIONS Russian patent published in 2016 - IPC G01N33/68 C12Q1/25 A61K38/17 C07K14/47 C12Q1/68

Abstract RU 2596486 C2

FIELD: medicine.

SUBSTANCE: invention relates to medicine and concerns a method, a test system for diagnosis of diabetic nephropathy. Disclosed method comprises determining in sample from a subject a biomarker, which is a similar CD5 antigen.

EFFECT: using method enables to diagnose diabetic nephropathy.

33 cl, 13 tbl, 4 dwg, 1 ex

Similar patents RU2596486C2

Title	Year	Author	Number
METHOD OF PERSONALIZED TREATMENT OF CHRONIC RENAL DISEASE IN PATIENTS WITH DIABETIC NEPHROPATHY	2018	Ibragimov Vagif Magomed-Eminovich Batyushin Mikhail Mikhajlovich Sarvilina Irina Vladislavovna Aliskandiev Alaudin Magomedovich	RU2687256C1
METHOD FOR DETECTING DIABETIC FETOPATHY	2020	Papysheva Olga Viulenovna Morozov Sergej Georgievich Kotajsh Galina Aleksandrovna Kajsheva Anna Leonidovna Mayatskaya Tatyana Aleksandrovna Kopylov Artur Tigranovich Kharitonova Lyubov Alekseevna Bogomaz Dmitrij Sergeevich Gribova Iveta Evgenevna	RU2742801C1
TREATING VASCULAR COMPLICATIONS OF DIABETES	2010	Fisher Bernkhard Lukas Rudol'F	RU2545718C2
METHOD FOR ASSESSING THE RISK OF DEVELOPING ALZHEIMER'S DISEASE USING A PANEL OF BLOOD PROTEINS	2021	Kononikhin Aleksej Sergeevich Semenov Savva Dmitrievich Brzhozovskij Aleksandr Gennadevich Gavrilova Svetlana Ivanovna Borkhers Kristof Germann Nikolaev Evgenij Nikolaevich	RU2794040C1
METHOD FOR PREDICTING RISK OF SUBJECTS CONTRACTING DIABETES MELLITUS AND/OR METABOLIC SYNDROME OR FOR DIAGNOSING METABOLIC SYNDROME IN SUBJECTS	2013	Bergmann Andreas Melander Olle	RU2685713C2
THERAPEUTIC TREATMENT OF METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY OR POTENTIAL DIABETES	2008	Kinkotta Ehntoni Kh.	RU2467743C2
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF DIABETES MELLITUS TYPE	2021	Papysheva Olga Viulenovna Morozov Sergej Georgievich Kotajsh Galina Aleksandrovna Kajsheva Anna Leonidovna Mayatskaya Tatyana Aleksandrovna Kopylov Artur Tigranovich Kharitonova Lyubov Alekseevna Bogomaz Dmitrij Sergeevich Gribova Iveta Evgenevna Sokerina Ekaterina Nikolaevna	RU2788106C1
METHOD FOR DETECTING TYPE 1 DIABETES MELLITUS	2020	Papysheva Olga Viulenovna Morozov Sergej Georgievich Kotajsh Galina Aleksandrovna Kajsheva Anna Leonidovna Mayatskaya Tatyana Aleksandrovna Kopylov Artur Tigranovich Kharitonova Lyubov Alekseevna Bogomaz Dmitrij Sergeevich Gribova Iveta Evgenevna Sokerina Ekaterina Nikolaevna	RU2752372C1
HISTONES AND/OR proADM AS MARKERS INDICATING ADVERSE EVENT	2017	Tsira Tim Shenikhen Andre Enkam Ann Krop Manne Kurdt Ingo Sharl Per-Emmanyuel	RU2765212C2
COMPOSITIONS, APPLICATIONS AND METHODS OF TREATING METABOLIC DISORDERS AND DISEASES	2012	Lin Lej Lindkhaut Darrin E.	RU2697762C2

RU 2 596 486 C2

Authors

Stoll Thomas

Bringans Scott

Winfield Kaye

Casey Tammy

Davis Wendy

Peters Kirsten

Davis Timothy

Lipscombe Richard

Dates

2016-09-10—Published

2011-09-20—Filed